NCT06775353View on ClinicalTrials.gov

To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome

CompletedOBSERVATIONAL
Enrollment

2,017

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

January 1, 2025

Conditions
Retinopathy of Prematurity (ROP)
Interventions
DRUG

Dexamethasone eyedrop

Infants who developed stages of pretreatment-requiring severe ROP were usually given one eyedrop of dexamethasone daily until the ROP changes regressed.

Trial Locations (1)

22185

Department of Clinical Sciences, Ophthalmology, Lund University, Skåne University Hospital, Lund, Sweden, Lund

All Listed Sponsors
lead

Region Skane

OTHER